drugset / Trial / NCT01368887

Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis

NCT01368887

Phase 2 Suspended 160 enrolled DermiPsor, Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the effectiveness of DermiPsor's DPS-102 (test product) in patients with scalp Psoroasis. The study is also intended to assess the safety of the product.

Timeline

Start
2013-04
Primary completion
2013-11
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcipotriol Small molecule Topical
Subject DPS-102 Unknown Topical
Comparator Nicotinamide Other / unclassified Topical

Indications